Serum copeptin in children exposed to maltreatment

Autor(es):Mostrar menos -

Coelho, Roberta ; Levandowski, Mateus L. ; Mansur, Rodrigo B. ; da Cunha, Graccielle Rodrigues ; Asevedo, Elson ; Zugman, Andre ; Salum, Giovanni A. ; Gadelha, Ary ; Pan, Pedro M. ; Rizzo, Lucas B. ; Manfro, Gisele ; Mari, Jair J. ; Rohde, Luis A. ; Miguel, Euripedes C. ; Bressan, Rodrigo A. ; Brietzke, Elisa ; Grassi-Oliveira, Rodrigo

• Tipo de documento: Artigo Científico
• Fonte: PSYCHIATRY AND CLINICAL NEUROSCIENCES; v. 70, n. 10, p. 434-441, OCT 2016.
• Citações Web of Science: 5

Resumo

AimChildhood maltreatment (CM) has been related to a persistent reprograming of stress-response. Copeptin is a marker of hypothalamic-pituitary-adrenal axis activation; however, few studies have examined copeptin levels in children exposed to CM. The aim of this study was to compare serum copeptin levels in children reporting child abuse and/or neglect and children with no history of CM. MethodsThis study included 65 children with a positive history of moderate to severe CM, as reported by themselves and their parent(s) during a clinical interview, and 71 children with no history of CM as a comparison group. CM was considered moderate to severe based on the child-reported frequency of being exposed to events related to sexual abuse, physical abuse, emotional abuse, emotional neglect, and/or physical neglect. Child psychopathology symptoms were assessed using the Child Behavior Checklist (CBCL). We measured serum copeptin concentration using enzyme-linked immunosorbent assay. ResultsChildren exposed to CM exhibited higher levels of serum copeptin compared to children without CM when controlling for sex, age, and psychiatric morbidity. The CBCL total score, including internalizing and externalizing symptoms, was higher in children with CM. We found no correlation between copeptin and CBCL scores for internalizing symptoms and externalizing symptoms. Conclusion CM is associated with copeptin serum levels independently of age, sex, and symptom severity. Copeptin is a promising new biomarker for children with a history of abuse and/or neglect. (AU)

• Processo FAPESP: 08/57896-8 - O Instituto Nacional da Psiquiatria do Desenvolvimento: uma nova abordagem para a psiquiatria tendo como foco as nossas crianças e o seu futuro
• Beneficiário: Eurípedes Constantino Miguel Filho
• Modalidade de apoio: Auxílio à Pesquisa - Temático